CAS No. |
90825-43-7 |
中文名称 |
磷酸钠((R)-2,3-二(棕榈酰氧基)丙基)((4R,5R,7R,10S,13R,18S)-13-氨甲酰基-4-甲酰基-7,10,18-三甲基-2,8,11,16,19-五氧代-5-((1R,2R)-1,2,3-三羟基丙基)-6-氧杂-3,9,12,17,20-五氮杂二十二烷-22-基) |
英文名称 |
Sodium (R)-2,3-bis(palmitoyloxy)propyl ((4R,5R,7R,10S,13R,18S)-13-carbamoyl-4-formyl-7,10,18-trimethyl-2,8,11,16,19-pentaoxo-5-((1R,2R)-1,2,3-trihydroxypropyl)-6-oxa-3,9,12,17,20-pentaazadocosan-22-yl) phosphate |
别名 |
MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE S | sodium;2-[[(2S)-2-[[(4R)-4-[[(2S)-2-[[(2R)-2-[(2R,3R,4R,5R)-2-acetamido-4,5,6-trihydroxy-1-oxohexan-3-yl]oxypropanoyl]amino]propanoyl]amino]-5-amino-5-oxopentanoyl]amino]propanoyl]amino]ethyl [(2R)-2,3-di(he |
标准英文名 |
sodium (R)-2,3-bis(palmitoyloxy)propyl ((4R,5R,7R,10S,13R,18S)-13-carbamoyl-4-formyl-7,10,18-trimethyl-2,8,11,16,19-pentaoxo-5-((1R,2R)-1,2,3-trihydroxypropyl)-6-oxa-3,9,12,17,20-pentaazadocosan-22-yl) phosphate |
分子式 |
C59H108N6NaO19P |
分子量 |
1259.50
|
精确分子量 |
1258.73
|
SMILES |
O=P(OC[C@H](OC(CCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O)(OCCNC([C@H](C)NC(CC[C@H](C(N)=O)NC([C@H](C)NC([C@@H](C)O[C@@H]([C@H](O)[C@H](O)CO)[C@H](C=O)NC(C)=O)=O)=O)=O)=O)[O-].[Na+] |
标准SMILES |
[Na+].CC(=O)N[C@@H](C=O)[C@@H](O[C@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(=O)N[C@@H](C)C(=O)NCCOP([O-])(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(N)=O)[C@H](O)[C@H](O)CO |
用途 |
Mifamurtide sodium is a muramyl dipeptide (MDP) analog and a non-specific immunomodulator that exerts its effects by stimulating immune responses through activation of macrophages and monocytes; it is a specific ligand for NOD2 and functions as an insulin sensitizer; it has potential applications in the research and treatment of rare diseases and osteosarcoma. |
InChIKey |
LRSAONQAUPMYDK-XNLRRNFISA-M |